Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema

American Journal of Ophthalmology
Andrew A MoshfeghiCarmen A Puliafito

Abstract

To report pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Retrospective, noncomparative, consecutive case series. Records were reviewed of all patients who developed pseudohypopyon after intravitreal triamcinolone acetonide injection at Bascom Palmer Eye Institute between January 1, 2002 and February 1, 2004. A total of 828 intravitreal triamcinolone acetonide injections were administered to 686 patients during the study period. A pseudohypopyon (fine white crystalline opacities in the inferior anterior chamber angle) and suspended white crystalline opacities in the aqueous humor developed after 7 of the 828 injections (0.8%); all pseudohypopyons occurred within 3 days of injection and resolved completely within 2 weeks. None of the 686 patients developed clinically suspected infectious endophthalmitis. A transient pseudohypopyon may occur in the early postinjection period after intravitreal triamcinolone acetonide injection. Unless progressive intraocular inflammation occurs, close observational management is indicated.

References

Dec 1, 1989·Archives of Ophthalmology·M H Heinemann
Jul 26, 2003·The British Journal of Ophthalmology·F K P Sutter, M C Gillies
Sep 10, 2003·Archives of Ophthalmology·Daniel B RothNauman A Chaudhry
Nov 5, 2003·American Journal of Ophthalmology·Darius M MoshfeghiWilliam F Mieler
Nov 12, 2003·Archives of Ophthalmology·Jost B JonasRobert F Degenring
Nov 12, 2003·Archives of Ophthalmology·Kirk R Wilhelmus

❮ Previous
Next ❯

Citations

May 26, 2005·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·I KreissigJ B Jonas
Aug 24, 2011·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Diamar Pardo-LópezManuel Díaz-Llopis
Apr 16, 2011·Advances in Therapy·Nikolas J S LondonJulia A Haller
Jun 27, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·J BaathR G Williams
Mar 29, 2008·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Christoph BitterChristian Surber
Dec 13, 2005·Retina·Igor KozakWilliam R Freeman
Jan 16, 2007·Retina·Ingrid U Scott, Harry W Flynn
Apr 18, 2009·Retina·Andrew A MoshfeghiDarius M Moshfeghi
Jul 9, 2009·Retina·Gholam A PeymanDarius M Moshfeghi
Mar 26, 2013·Journal of Ophthalmic Inflammation and Infection·Nikolas Js LondonEmmett T Cunningham
Aug 12, 2009·Clinical Ophthalmology·Steven M Couch, Sophie J Bakri
May 17, 2013·Ophthalmic Surgery, Lasers & Imaging Retina·Zayna NahasHarry W Flynn
Apr 7, 2006·Ocular Immunology and Inflammation·Bram van KooijPhilip de Vries
Aug 17, 2006·Ocular Immunology and Inflammation·Mei-Ling Tay-Kearney
Nov 10, 2011·Expert Opinion on Drug Safety·Daniele VerittiPaolo Lanzetta
Oct 18, 2014·Expert Opinion on Drug Safety·Miguel Cordero-ComaTaygan Yilmaz
Jul 20, 2006·The Kaohsiung Journal of Medical Sciences·Kai-Chun Cheng, Wen-Chuan Wu
Jun 19, 2013·Survey of Ophthalmology·Weerawat KiddeeYvonne M Buys
Sep 14, 2012·Mediators of Inflammation·Joaquín MarticorenaFrancisco Gómez-Ulla
Feb 11, 2012·Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye·Brett P BieloryTimothy G Murray
Jan 8, 2014·Ophthalmic Surgery, Lasers & Imaging Retina·Mariana CabreraJean-Marie A Parel
Apr 19, 2008·Experimental Eye Research·Yi-Sheng ChangShih-Ya Tseng
Aug 28, 2007·Survey of Ophthalmology·C M JermakG A Peyman
May 1, 2007·The Veterinary Journal·José M MolledaEva M Martín-Suárez
Jan 17, 2007·Ophthalmology·Yaron LangIdo Perlman
May 8, 2010·Clinical & Experimental Ophthalmology·Sumu SimonJagjit Gilhotra
Mar 28, 2006·American Journal of Ophthalmology·John T Thompson
Dec 6, 2005·Ophthalmology·Jane-Ming LinPor-Tying Hung
Oct 18, 2005·American Journal of Ophthalmology·Teresio AvitabileAlfredo Reibaldi
Sep 20, 2005·Experimental Eye Research·Michael R RobinsonKarl G Csaky
Jul 12, 2005·Progress in Retinal and Eye Research·Jost B JonasRobert Degenring
Dec 29, 2013·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Ali M Al-Halafi
Apr 24, 2007·International Ophthalmology Clinics·Janie Ho, John I Loewenstein
Sep 18, 2018·Current Opinion in Ophthalmology·Ramana S MoorthyEmmett T Cunningham
Nov 7, 2006·Acta Ophthalmologica Scandinavica·Sobha SivaprasadSusan Lightman
Apr 9, 2010·Current Opinion in Ophthalmology·Kapil M Sampat, Sunir J Garg
Jun 10, 2006·Ophthalmic Research·Jost B Jonas
Jul 10, 2009·Expert Opinion on Pharmacotherapy·Stephen G SchwartzIngrid U Scott

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.